Piramal Pharma Limited, a flagship company of the Piramal Group, was founded in 2020 to offer pharmaceutical products and services over a domestic and global distribution network. The company maintains 15 global manufacturing facilities and has a global distribution network that spans more than 100 countries.
Piramal Pharma includes:
- Piramal Pharma Solutions (PPS) is a CDMO which specialises in contract development and manufacturing. It develops and manufactures solutions for innovators and generic businesses through a globally integrated network of facilities across the drug life cycle.
- Piramal Critical Care (PCC) is a Complex Hospital Generics business that offers inhalation anesthetics, intrathecal therapies for spasticity and pain management, injectable pain and
anesthetics, injectable anti-infectives, and other therapies. India Consumer Healthcare (ICH) business, selling over-the-counter products.
Criterias of the Issue:
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
- Repayment or prepayment, in full or in part, of certain borrowings.
- General corporate purposes.
Piramal Pharma Rights Issue 2023 Detail
| Issue Open | |
| Security Name | Piramal Pharma Limited |
| Issue Size (Shares) | [.] |
| Issue Size (Amount) | ₹1,050.00 Crores |
| Issue Price | |
| Face Value | ₹10 per share |
| Listing At | BSE, NSE |
| Terms of Payment | |
| Entitlement |
Piramal Pharma Limited Financial Information (Restated Consolidated)
Company Contact Information
Piramal Pharma Limited
Ground Floor, Piramal Ananta,
Agastya Corporate Park, Kamani Junction,
LBS Marg, Kurla, Mumbai 400 070
Phone: +91 22 3802 3000
Email: shareholders.ppl@piramal.com
Website: https://www.piramal.com
Piramal Pharma Rights Issue 2023 Registrar
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: ppl.rights@linkintime.co.in
Website: https://linkintime.co.in
Piramal Pharma Rights Issue 2023 Lead Manager(s)
- Icici Securities Limited
Piramal Pharma Rights Issue 2023 FAQs
Q1. When is Piramal Pharma Rights Issue 2023 coming?
Ans. The Piramal Pharma Rights Issue 2023 open and close dates are not available as of now.
Q2. What is the issue price for Piramal Pharma Rights Issue 2023?
Ans. The price of the Piramal Pharma Rights Issue 2023 is not yet set.
Q3. In what ratio is the Piramal Pharma Rights Issue 2023 offered?
Ans. The Piramal Pharma Rights Issue 2023 ratio is not yet declared.
Q4. What is the record date for Piramal Pharma Rights Issue 2023?
Ans. The Piramal Pharma Rights Issue 2023 record date is not yet declared.
Q5. What is the issue size of Piramal Pharma Rights Issue 2023?
Ans. The issue size of Piramal Pharma Rights Issue 2023 is of [.] equity shares at aggregating upto ₹1,050.00 Crores.
Q6. How to apply for Piramal Pharma Rights Issue 2023?
Ans. You can apply for Piramal Pharma Rights Issue 2023 in two ways:
- Net Banking (ASBA)
- Registrar’s Website (R-WAP Facility)
Steps to apply for Piramal Pharma Rights Issue 2023 using Net Banking (ASBA)
- Log in to the net banking account of your bank.
- Go to the ‘IPO & Rights Issue’ section.
- Check if the Piramal Pharma Rights Issue 2023 available on the list.
- Click the Apply button next to the Piramal Pharma Rights Issue 2023.
- Fill and check your information.
- Submit the application.
Note: Your bank may not offer this facility to certain rights issues. In that case, you may have to choose the option below.
Steps to apply for Piramal Pharma Rights Issue 2023 using Registrar’s website (R-WAP)
- Visit registrar’s website
- Go to the ‘Rights Issue’ section
- Select Piramal Pharma Rights Issue 2023 from the dropdown.
- Enter Demat Account Number.
- Fill the online application form.
- Validate and submit the application.
